Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2006
by City Hospitals Sunderland NHS Foundation Trust.
Recruitment status was Active, not recruiting
Study NCT00108706 Information provided by City Hospitals Sunderland NHS Foundation Trust
First Received on April 18, 2005. Last Updated on September 11, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cerebrovascular Accident
Acute Stroke
Additional conditions recognized in this trial
Cerebral Infarction
Stroke
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Candesartan
Additional drug interventions recognized in this trial
Angiotensin Receptor Antagonists
Candesartan cilexetil
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
City Hospitals Sunderland NHS Foundation Trust
Takeda Global Research & Development Center, Inc.
Back to top of Main Content